Prescreening patients with Parkinson’s disease (PD) for realistic expectations about deep brain stimulation (DBS) may improve efficiency and outcomes.
Why this matters ?
DBS is a risky procedure, but can be a helpful treatment for people with PD, and clinical-based intensive screening to select the people who will benefit the most has minimized the risks associated with DBS.
However, this screening is expensive and rigorous, and a cheaper, specific prescreening may improve DBS outcomes.
It has been reported that people with unrealistic or uneducated expectations of DBS have poorer outcomes; therefore, patients’ expectations of DBS may be a clinically relevant prescreening factor.